melanoma

dominoes fall series fail
Biotech

Krystal discontinues melanoma study after FDA's Replimune rebuff

The FDA’s rebuff of Replimune’s melanoma candidate has rippled across the industry, prompting Krystal Biotech to shutter a clinical trial.
Gabrielle Masson Aug 21, 2025 10:50am
dart board miss failure

Cancer vaccine's 'narrow' fail won't stop IO heading to FDA

Aug 11, 2025 9:48am
arrow choose one big pick forward many

Scancell picks winner from phase 2 cancer vaccine face-off

Jul 22, 2025 9:38am
Image of a neon sign with the word no lit up next to an unlit yes

Replimune's request for melanoma approval rejected by FDA

Jul 22, 2025 8:45am
pendulum silver metallic spheres on coloured background with drop shadow

As investors pivot from cell therapy, Immatics keeps the faith

Jun 6, 2025 3:50am
pile of cash piggy bank money cash dollars bills spend

Pathos AI's $365M series D to fund trial of Novo tumor drug

May 15, 2025 10:20am